financetom
Business
financetom
/
Business
/
Crown Castle Names Christian Hillabrant Chief Executive; Dan Schlanger to Become Chief Transformation Officer
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Crown Castle Names Christian Hillabrant Chief Executive; Dan Schlanger to Become Chief Transformation Officer
Aug 5, 2025 2:46 AM

05:28 AM EDT, 08/05/2025 (MT Newswires) -- Crown Castle ( CCI ) said late Monday its board has appointed Christian Hillabrant as president and chief executive officer, effective Sept. 15.

Hillabrant, who most recently served as CEO and chairman of Vantage Towers AG, will succeed Dan Schlanger, who served on an interim basis.

Schlanger is expected to be appointed as chief transformation officer.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: Mastercard Plans to Cut 3% of Staff Worldwide
Market Chatter: Mastercard Plans to Cut 3% of Staff Worldwide
Aug 16, 2024
01:32 PM EDT, 08/16/2024 (MT Newswires) -- Mastercard ( MA ) intends to cut 3% of its staff worldwide, Bloomberg reported Friday, citing a company spokesperson. The cuts would amount to about 1,000 people, according to the report, which cited Mastercard's ( MA ) reported employee headcount at the end of 2023. The majority of the job cuts are expected...
Why Is B. Riley Financial Stock Jumping Today?
Why Is B. Riley Financial Stock Jumping Today?
Aug 16, 2024
B. Riley Financial, Inc. ( RILY ) shares are trading higher after the company, in a 13D filing, disclosed that co-founder Bryant R. Riley wrote a letter to the Board of Directors with a proposal to acquire all shares of common stock that he does not own for a price of $7 per share. Riley is the largest stockholder of...
Tonix Pharmaceuticals' Live Virus Vaccine Candidate Shows Long-Term Protection From Mpox, Smallpox With 1 Dose, Animal Study Suggests
Tonix Pharmaceuticals' Live Virus Vaccine Candidate Shows Long-Term Protection From Mpox, Smallpox With 1 Dose, Animal Study Suggests
Aug 16, 2024
Friday, Tonix Pharmaceuticals Holding Corp. ( TNXP ) reiterated its commitment to advancing the development of its live attenuated virus vaccine, TNX-801 (recombinant horsepox virus), to prevent mpox and other infectious diseases. As per data from Benzinga Pro, Tonix Pharmaceuticals ( TNXP ) has a strong session volume of 53.33 million on Friday. Mpox is an infectious viral disease that...
--Mastercard Plans to Cut 3% of Staff Worldwide, Bloomberg Reports
--Mastercard Plans to Cut 3% of Staff Worldwide, Bloomberg Reports
Aug 16, 2024
01:26 PM EDT, 08/16/2024 (MT Newswires) -- Price: 469.87, Change: +1.16, Percent Change: +0.25 ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved